Annual Operating Profit
$168.34 M
-$82.00 M-32.76%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual operating income is $168.34 million, with the most recent change of -$82.00 million (-32.76%) on December 31, 2023.
- During the last 3 years, IRWD annual operating profit has risen by +$10.01 million (+6.33%).
- IRWD annual operating profit is now -32.76% below its all-time high of $250.34 million, reached on December 31, 2022.
Performance
IRWD Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$25.65 M
-$1.39 M-5.15%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly operating income is $25.65 million, with the most recent change of -$1.39 million (-5.15%) on September 30, 2024.
- Over the past year, IRWD quarterly operating profit has stayed the same.
- IRWD quarterly operating profit is now -62.54% below its all-time high of $68.47 million, reached on September 30, 2022.
Performance
IRWD Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$107.36 M
-$19.06 M-15.07%
September 30, 2024
Summary
- As of February 20, 2025, IRWD TTM operating income is $107.36 million, with the most recent change of -$19.06 million (-15.07%) on September 30, 2024.
- Over the past year, IRWD TTM operating profit has stayed the same.
- IRWD TTM operating profit is now -57.49% below its all-time high of $252.59 million, reached on March 31, 2023.
Performance
IRWD TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
IRWD Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.8% | 0.0% | 0.0% |
| 3 y3 years | +6.3% | -54.7% | -53.8% |
| 5 y5 years | +1225.3% | -54.7% | -53.8% |
IRWD Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.8% | at low | -62.5% | +123.9% | -57.5% | at low |
| 5 y | 5-year | -32.8% | +43.8% | -62.5% | +123.9% | -57.5% | at low |
| alltime | all time | -32.8% | +166.8% | -62.5% | +128.9% | -57.5% | +142.6% |
Ironwood Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $25.65 M(-5.1%) | $107.36 M(-15.1%) |
| Jun 2024 | - | $27.04 M(+136.0%) | $126.42 M(+5.6%) |
| Mar 2024 | - | $11.46 M(-73.5%) | $119.70 M(-28.9%) |
| Dec 2023 | $168.34 M(-32.8%) | $43.21 M(-3.4%) | $168.34 M(-13.0%) |
| Sep 2023 | - | $44.71 M(+120.0%) | $193.49 M(-10.9%) |
| Jun 2023 | - | $20.32 M(-66.2%) | $217.25 M(-14.0%) |
| Mar 2023 | - | $60.10 M(-12.1%) | $252.59 M(+0.9%) |
| Dec 2022 | $250.34 M(+7.8%) | $68.36 M(-0.2%) | $250.34 M(+4.9%) |
| Sep 2022 | - | $68.47 M(+23.0%) | $238.57 M(+1.4%) |
| Jun 2022 | - | $55.66 M(-3.8%) | $235.19 M(-3.7%) |
| Mar 2022 | - | $57.85 M(+2.2%) | $244.35 M(+5.2%) |
| Dec 2021 | $232.22 M(+46.7%) | $56.59 M(-13.1%) | $232.22 M(-3.7%) |
| Sep 2021 | - | $65.10 M(+0.4%) | $241.16 M(+8.2%) |
| Jun 2021 | - | $64.82 M(+41.8%) | $222.91 M(+16.8%) |
| Mar 2021 | - | $45.71 M(-30.3%) | $190.80 M(+20.5%) |
| Dec 2020 | $158.32 M(+35.3%) | $65.53 M(+39.9%) | $158.32 M(+11.2%) |
| Sep 2020 | - | $46.85 M(+43.2%) | $142.35 M(-9.7%) |
| Jun 2020 | - | $32.71 M(+147.3%) | $157.69 M(+9.6%) |
| Mar 2020 | - | $13.23 M(-73.3%) | $143.88 M(+22.9%) |
| Dec 2019 | $117.04 M(-882.4%) | $49.56 M(-20.3%) | $117.04 M(+19.4%) |
| Sep 2019 | - | $62.19 M(+229.1%) | $98.05 M(+509.9%) |
| Jun 2019 | - | $18.90 M(-238.9%) | $16.07 M(-231.6%) |
| Mar 2019 | - | -$13.61 M(-144.5%) | -$12.22 M(-61.3%) |
| Dec 2018 | -$14.96 M(-67.7%) | $30.57 M(-254.5%) | -$31.54 M(+92.2%) |
| Sep 2018 | - | -$19.78 M(+110.6%) | -$16.41 M(-1.3%) |
| Jun 2018 | - | -$9.39 M(-71.5%) | -$16.62 M(-59.7%) |
| Mar 2018 | - | -$32.93 M(-172.1%) | -$41.21 M(-11.1%) |
| Dec 2017 | -$46.36 M(+11.3%) | $45.70 M(-328.6%) | -$46.36 M(-52.1%) |
| Sep 2017 | - | -$19.99 M(-41.2%) | -$96.83 M(+0.4%) |
| Jun 2017 | - | -$33.98 M(-10.8%) | -$96.45 M(+24.0%) |
| Mar 2017 | - | -$38.09 M(+699.9%) | -$77.79 M(+86.7%) |
| Dec 2016 | -$41.66 M | -$4.76 M(-75.7%) | -$41.66 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$19.62 M(+28.1%) | -$42.73 M(+7.3%) |
| Jun 2016 | - | -$15.31 M(+678.2%) | -$39.81 M(-31.8%) |
| Mar 2016 | - | -$1.97 M(-66.2%) | -$58.35 M(-30.9%) |
| Dec 2015 | -$84.45 M(-43.4%) | -$5.83 M(-65.1%) | -$84.45 M(-15.8%) |
| Sep 2015 | - | -$16.70 M(-50.7%) | -$100.35 M(-16.6%) |
| Jun 2015 | - | -$33.86 M(+20.6%) | -$120.39 M(-15.0%) |
| Mar 2015 | - | -$28.07 M(+29.2%) | -$141.65 M(-10.3%) |
| Dec 2014 | -$149.08 M(-40.8%) | -$21.73 M(-40.9%) | -$157.97 M(-13.7%) |
| Sep 2014 | - | -$36.74 M(-33.3%) | -$182.98 M(-9.8%) |
| Jun 2014 | - | -$55.12 M(+24.2%) | -$202.79 M(-2.3%) |
| Mar 2014 | - | -$44.39 M(-5.0%) | -$207.56 M(-17.6%) |
| Dec 2013 | -$252.00 M(+246.3%) | -$46.74 M(-17.4%) | -$252.00 M(+1.1%) |
| Sep 2013 | - | -$56.55 M(-5.6%) | -$249.16 M(+71.8%) |
| Jun 2013 | - | -$59.88 M(-32.6%) | -$145.00 M(+15.1%) |
| Mar 2013 | - | -$88.83 M(+102.4%) | -$125.96 M(+73.1%) |
| Dec 2012 | -$72.76 M(+10.0%) | -$43.90 M(-192.2%) | -$72.76 M(+102.7%) |
| Sep 2012 | - | $47.61 M(-216.6%) | -$35.89 M(-65.9%) |
| Jun 2012 | - | -$40.83 M(+14.6%) | -$105.12 M(+26.3%) |
| Mar 2012 | - | -$35.64 M(+406.8%) | -$83.24 M(+25.8%) |
| Dec 2011 | -$66.14 M(+8.8%) | -$7.03 M(-67.5%) | -$66.14 M(-8.0%) |
| Sep 2011 | - | -$21.62 M(+14.1%) | -$71.91 M(+8.2%) |
| Jun 2011 | - | -$18.95 M(+2.2%) | -$66.45 M(+2.5%) |
| Mar 2011 | - | -$18.54 M(+44.9%) | -$64.81 M(+6.7%) |
| Dec 2010 | -$60.77 M(-0.1%) | -$12.79 M(-20.8%) | -$60.77 M(-12.4%) |
| Sep 2010 | - | -$16.16 M(-6.6%) | -$69.34 M(+12.8%) |
| Jun 2010 | - | -$17.31 M(+19.4%) | -$61.46 M(-2.0%) |
| Mar 2010 | - | -$14.50 M(-32.2%) | -$62.73 M(-6.1%) |
| Dec 2009 | -$60.82 M(+8.8%) | -$21.37 M(+157.8%) | -$66.80 M(+7.3%) |
| Sep 2009 | - | -$8.29 M(-55.4%) | -$62.23 M(+15.4%) |
| Jun 2009 | - | -$18.58 M(+0.0%) | -$53.95 M(+52.5%) |
| Mar 2009 | - | -$18.57 M(+10.5%) | -$35.37 M(+110.5%) |
| Dec 2008 | -$55.92 M(-2.9%) | -$16.80 M | -$16.80 M |
| Dec 2007 | -$57.62 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual operating profit year-on-year change?
- What is Ironwood Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly operating profit year-on-year change?
- What is Ironwood Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM operating profit year-on-year change?
What is Ironwood Pharmaceuticals annual operating income?
The current annual operating profit of IRWD is $168.34 M
What is the all time high annual operating profit for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual operating income is $250.34 M
What is Ironwood Pharmaceuticals annual operating profit year-on-year change?
Over the past year, IRWD annual operating income has changed by -$82.00 M (-32.76%)
What is Ironwood Pharmaceuticals quarterly operating income?
The current quarterly operating profit of IRWD is $25.65 M
What is the all time high quarterly operating profit for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly operating income is $68.47 M
What is Ironwood Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, IRWD quarterly operating income has changed by $0.00 (0.00%)
What is Ironwood Pharmaceuticals TTM operating income?
The current TTM operating profit of IRWD is $107.36 M
What is the all time high TTM operating profit for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM operating income is $252.59 M
What is Ironwood Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, IRWD TTM operating income has changed by $0.00 (0.00%)